Lélia DelamarreSenior Scientist, Cancer Immunology Discovery at Genentech
Lélia Delamarre is a Senior Scientist in the Cancer Immunology Department at Genentech. Her research interest is to understand how the modulation of dendritic cell and T cell functions can enhance tumor-specific T cell responses. More recently her group focused on the identification and characterization of the neoantigens that drive protective immune responses to cancer with the goal of using this information for the development of individualized neoantigen-specific therapies against cancer, including therapeutic vaccines, and the development of novel tools for immune monitoring of patients. Lélia Delamarre obtained a PhD in Virology from Pierre and Marie Curie University in France and then, completed a postdoctoral training at Yale University, where she studied the cell biology of antigen presentation in dendritic cells.